Cargando…

Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis

BACKGROUND: Immune checkpoint inhibitor-related myocarditis is the deadliest complication of immunotherapy. However, the underlying pathophysiological mechanisms of its occurrence and development remain unclear. Due to the long-term lack of effective early diagnosis and treatment options, it is of g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Gan, Yi, Zhu, Haoshuai, Liu, Zhihao, Yao, Xiaojing, Cheng, Chao, Liu, Zhenguo, Su, Chunhua, Zou, Jianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902768/ https://www.ncbi.nlm.nih.gov/pubmed/36760573 http://dx.doi.org/10.3389/fcvm.2023.1112222

Ejemplares similares

Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms
por: Rikhi, Rishi, et al.
Publicado: (2021)

A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer
por: Faubry, Clara, et al.
Publicado: (2022)

Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using (68)Ga-FAPI PET/CT
por: Finke, Daniel, et al.
Publicado: (2021)

Neurological outcomes of extended thymectomy for thymomatous myasthenia gravis: Subxiphoid vs. trans-sternal approaches
por: Zhu, Haoshuai, et al.
Publicado: (2022)

Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment
por: Luo, Yue-Bei, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors and the Heart
por: Mocan-Hognogi, Diana Larisa, et al.
Publicado: (2021)

Role of glycosphingolipid biosynthesis coregulators in malignant progression of thymoma
por: Zhang, Xin, et al.
Publicado: (2023)

Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
por: She, Jianqing, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
por: Inno, Alessandro, et al.
Publicado: (2021)

Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors
por: Chen, Ru, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis
por: Chen, Xue, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies
por: Xu, Shirley, et al.
Publicado: (2021)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

Clinical Identification and Characteristic Analysis of Giant Cell Myocarditis in 12 Cases
por: Liu, Shangyu, et al.
Publicado: (2021)

Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience
por: Xiao, Junjuan, et al.
Publicado: (2023)

Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
por: Hu, Yuxiao, et al.
Publicado: (2021)

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
por: Chye, Adrian M., et al.
Publicado: (2022)

Fatal cerebral haemorrhagic infarction due to left ventricular thrombus after healing of immune checkpoint inhibitor-associated myocarditis
por: Sakai, Shunsuke, et al.
Publicado: (2020)

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment
por: Ganesh, Sridha, et al.
Publicado: (2022)

Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options
por: Maisch, Bernhard
Publicado: (2019)

Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
por: Dai, Haijiang, et al.
Publicado: (2021)

Myocarditis in Humans and in Experimental Animal Models
por: Błyszczuk, Przemysław
Publicado: (2019)

Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni
por: Kojima, Nobuko, et al.
Publicado: (2022)

Severe T-System Remodeling in Pediatric Viral Myocarditis
por: Fiegle, Dominik J., et al.
Publicado: (2021)

The Roles of Cardiac Fibroblasts and Endothelial Cells in Myocarditis
por: Xuan, Yunling, et al.
Publicado: (2022)

Viral Myocarditis: Classification, Diagnosis, and Clinical Implications
por: Sozzi, Fabiola B., et al.
Publicado: (2022)

Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022
por: Wu, Si, et al.
Publicado: (2022)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou, Wenlu, et al.
Publicado: (2021)

Case report: Myocarditis following COVID-19 protein subunit vaccination
por: Dong, Yi-ming, et al.
Publicado: (2022)

Advances in cell death mechanisms involved in viral myocarditis
por: Yang, Yang, et al.
Publicado: (2022)

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Cardiac Complications in Immune Checkpoint Inhibition Therapy
por: Tajiri, Kazuko, et al.
Publicado: (2019)

Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
por: Tanabe, Junya, et al.
Publicado: (2020)

Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
por: Jiménez-Alejandre, Rosa, et al.
Publicado: (2022)

Neutrophil infiltration and myocarditis in patients with severe COVID-19: A post-mortem study
por: Zhang, Quanyu, et al.
Publicado: (2022)

Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis
por: Cui, Guanglin, et al.
Publicado: (2022)

Case Report: Hypothyroidism Misdiagnosed as Fulminant Myocarditis in a Child
por: Zhang, Nanjun, et al.
Publicado: (2021)

Editorial: Myocarditis and inflammatory cardiomyopathies: diagnosis, treatment and future directions
por: Gentile, Piero, et al.
Publicado: (2023)

Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report
por: Lin, Yunling, et al.
Publicado: (2022)

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
por: Liu, Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23lqutbvn7k54nual37m07q9kj